Researchers have been developing diagnostic tools, potential vaccines and drugs to fight viruses. The transmission of a newly identified coronavirus SARS-CoV-2 (formerly 2019-nCoV) is very strong. GenScript now offers comprehensive portfolio of off the shelf products for SARS-CoV-2 research. All the proteins for COVID-19 research serve as excellent antigens in ELISA and Western Blot and in the rapid detection of relative virus seroconverters with optimal specificity.
Proteins
| Variants | Proteins | Mutation site | Tag | Cat. No |
|---|---|---|---|---|
| 20I/501Y.V1, VOC 202012/01, or B.1.1.7 (United Kingdom) |
S1 Protein | N501Y | C-terminal His | Z03526 |
| del(69-70) | Z03523 | |||
| D614G | Z03507 | |||
| P681H | Z03527 | |||
| del(69-70)+N439K | Z03524 | |||
| del Y144 | Z03522 | |||
| A222V | Z03520 | |||
| A570D | Z03521 | |||
| S-RBD | N501Y | C-terminal Avi & His | Z03533 | |
| 20H/501Y.V2 or B.1.351 (South Africa) |
S1 Protein | N501Y | C-terminal His | Z03526 |
| E484K | Z03529 | |||
| K417N | Z03530 | |||
| E484K+K417N+N501Y | Z03531 | |||
| S-RBD | N501Y | C-terminal Avi & His | Z03533 | |
| E484K | Z03535 | |||
| K417N | Z03536 | |||
| E484K+K417N+N501Y | Z03537 | |||
| Other | S1 Protein | N439K | C-terminal His | Z03525 |
| Y453F | Z03528 | |||
| S-RBD | N439K | C-terminal Avi & His | Z03532 | |
| Y453F | Z03534 |
Antibodies
| Cat. No. | Description | Type | Clone ID | Recommend applications | Recommended pairs(Capture-Detection) |
|---|---|---|---|---|---|
| A02087 | Neutralizing Antibody Standard Hot! | - | - | Calibrate quantitative assay of SARS-CoV-2 neutralizing antibody (sVNT, PRNT, pVNT) | - |
| A02038 | Control antibody | Chimeric mAb, IgG | HC2001 | ELISA | - |
| A02046 | Chimeric mAb, IgM | hIgM2001 | ELISA | - | |
| A02071 | Chimeric mAb, IgA | hIgA2001 | ELISA | - | |
| A02088 | Neutralizing Antibody | Chimeric mAb, IgM | R323IgM | ELISA | - |
| A02051 | Rabbit mAb | BS-R2B2 | ELISA, FACS, Neu | A02058-A02051 | |
| A02052 | BS-R2B17 | ELISA, FACS, Neu | - | ||
| A02053 | 4G6 | ELISA, FACS, WB, Neu | - | ||
| A02054 | 12D3 | ELISA, FACS, Neu | - | ||
| A02055 | Mouse mAb | 6D11F2 | ELISA, FACS, Neu | - | |
| A02056 | 5B7D7 | ELISA, FACS, Neu | - | ||
| A02057 | BS-M0220 | ELISA, Neu | - | ||
| A02058 | Antibody Pairs | Rabbit mAb | BS-R2B12 | ELISA, FACS | A02058-A02051 |
| Cat. No. | Description | Type | Clone ID | Recommend applications | Recommended pairs(Capture-Detection) |
|---|---|---|---|---|---|
| A02039 | Control antibody | Chimeric mAb, IgG | HC2003 | ELISA | - |
| A02059 | Chimeric mAb, IgM | hlgM2003 | ELISA | - | |
| A02090 | Chimeric mAb, IgA | N22IgA | ELISA | - | |
| A02047 | Antibody Pairs | Mouse mAb | 3H11 | ELISA, WB | A02047-A02048 |
| A02048 | 4H2 | ELISA, WB | A02047-A02048 A02049-A02048 | ||
| A02049 | 3F9 | ELISA, WB | A02049-A02048 A02050-A02049 | ||
| A02050 | 23F2 | ELISA, WB | A02050-A02049 | ||
| A02085 | N42 | ELISA, LFA | A02039-A02085 | ||
| A02082 | Chimeric mAb, IgG | N32HC | ELISA | A02082-A02084 | |
| A02083 | N31HC | ELISA, LFA | A02083-A02039 | ||
| A02084 | N39HC | ELISA | A02082-A02084 A02084-A02086 |
||
| A02086 | N42HC | ELISA, LFA | A02086-A02083 |
| Cat.No. | Product Name | Price |
|---|---|---|
| A01854-200 | Mouse Anti-Human IgG Fc Antibody[HRP], mAb - 200 μl | $99.00 |
| A01428-100 | THE™ DYKDDDDK Tag Antibody [HRP], mAb, Mouse | $149.00 |
| A00612 | THE™ His Tag Antibody [HRP], mAb, Mouse | $410.00 |
| M00091 | Streptavidin-HRP | $89.00 |
Serology Detection Kits
Peptide Pools
| Cat. No. | Product Name | Quantity | Price |
|---|---|---|---|
RP30025 |
SARS-CoV-2 Spike Glycoprotein D614G - 2 vials(25µg/peptide) |
$716.00 |
|
RP30026 |
SARS-CoV-2 Spike Glycoprotein RBD N501Y - 1 vial(25µg/peptide) |
$327.00 |
|
RP30010 |
HCoV-229E Spike Glycoprotein - 2 vials(25µg/peptide) |
$716.00 |
|
RP30011 |
HCoV-OC43 Spike glycoprotein - 2 vials(25µg/peptide) |
$716.00 |
|
RP30020 |
SARS-CoV-2 Spike Glycoprotein-crude - 2 vials(25µg/peptide) |
$716.00 |
|
RP30027 |
SARS-CoV-2 Spike Glycoprotein-90% purity - 2 vials(25µg/peptide) |
$1002.00 |
|
RP30012 |
SARS-CoV-2 ORF3a - 1 vial(25µg/peptide) |
$327.00 |
|
RP30014 |
SARS-CoV-2 ORF6 - 1 vial(25µg/peptide) |
$253.00 |
|
RP30016 |
SARS-CoV-2 ORF7a - 1 vial(25µg/peptide) |
$253.00 |
|
RP30015 |
SARS-CoV-2 ORF7b - 1 vial(25µg/peptide) |
$253.00 |
|
RP30017 |
SARS-CoV-2 ORF8 - 1 vial(25µg/peptide) |
$253.00 |
|
RP30019 |
SARS-CoV-2 ORF9B - 1 vial(25µg/peptide) |
$253.00 |
|
RP30018 |
SARS-CoV-2 ORF10 - 1 vial(25µg/peptide) |
$253.00 |
|
RP30021 |
SARS-CoV-2 E - 1 vial(25µg/peptide) |
$253.00 |
|
RP30022 |
SARS-CoV-2 M - 1 vial(25µg/peptide) |
$327.00 |
|
RP30013 |
SARS-CoV-2 N - 1 vial(25µg/peptide) |
$331.00 |
|
RP30023 |
SARS-CoV-2 Y14 - 1 vial(25µg/peptide) |
$253.00 |
Stable Cell Lines
| Protein of Expression | Cell Line | Cat.No. |
|---|---|---|
| ACE2 | HEK293/ACE2 | M00770 |
| ACE2 | CHO-K1/ACE2 | M00771 |
| SARS-CoV-2 Spike protein | CHO-K1/Spike Stable Cell Line | M00803 |
| SARS-CoV-2 Spike protein | HEK293T/Spike Stable Cell Line | M00804 |
Webinars
-
COVID-19 - mechanism, infection rate and tools for monitoring
-
Pathways for treating and eradicating COVID-19 with solutions to minimize time to results
